No paradigm changes with checkpoint inhibitor monotherapy in patients with metastatic renal cell carcinoma and brain metastases
Ann Transl Med
.
2019 Nov;7(22):612.
doi: 10.21037/atm.2019.11.50.
Authors
Sergio Bracarda
1
,
Claudia Mosillo
1
,
Fabio Trippa
2
,
Federica Urbano
1
,
Ernesto Maranzano
2
,
Claudia Caserta
1
Affiliations
1
Medical Oncology Unit, Azienda Ospedaliera S. Maria, Terni, Italy.
2
Radiotherapy Oncology Centre, Azienda Ospedaliera S. Maria, Terni, Italy.
PMID:
31930013
PMCID:
PMC6944575
DOI:
10.21037/atm.2019.11.50
No abstract available
Publication types
Editorial
Comment